AJJ Medtech Holdings (SGX:584) PB Ratio: (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AJJ Medtech Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-23), AJJ Medtech Holdings's share price is S$0.004. AJJ Medtech Holdings's Book Value per Share for the quarter that ended in Mar. 2026 was S$-0.00. Hence, AJJ Medtech Holdings's PB Ratio of today is .

The historical rank and industry rank for AJJ Medtech Holdings's PB Ratio or its related term are showing as below:

During the past 13 years, AJJ Medtech Holdings's highest PB Ratio was 1.61. The lowest was 0.17. And the median was 0.50.

SGX:584's PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.14
* Ranked among companies with meaningful PB Ratio only.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of AJJ Medtech Holdings was -4.80% per year. The lowest was -50.00% per year. And the median was -20.60% per year.

Back to Basics: PB Ratio


AJJ Medtech Holdings  (SGX:584) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


AJJ Medtech Holdings PB Ratio Related Terms


AJJ Medtech Holdings PB Ratio Historical Data

* Premium members only.

The historical data trend for AJJ Medtech Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AJJ Medtech Holdings PB Ratio Chart

AJJ Medtech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 8.00 0.00 0.00 0.00

AJJ Medtech Holdings Quarterly Data
Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SGX:584 vs ABT, SYK, MDT: PB Ratio Comparison

For the Medical Devices subindustry, AJJ Medtech Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AJJ Medtech Holdings PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AJJ Medtech Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where AJJ Medtech Holdings's PB Ratio falls into.



AJJ Medtech Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AJJ Medtech Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=0.004/-0.002
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


AJJ Medtech Holdings Business Description

Address 8 Commonwealth Lane, No. 02-04, Grande Building, Singapore, SGP, 149555
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.